Takuya Suzuki

2.7k total citations
103 papers, 2.1k citations indexed

About

Takuya Suzuki is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Takuya Suzuki has authored 103 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 22 papers in Surgery and 22 papers in Molecular Biology. Recurrent topics in Takuya Suzuki's work include Thyroid Cancer Diagnosis and Treatment (16 papers), Colorectal Cancer Surgical Treatments (15 papers) and Nanoparticle-Based Drug Delivery (9 papers). Takuya Suzuki is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (16 papers), Colorectal Cancer Surgical Treatments (15 papers) and Nanoparticle-Based Drug Delivery (9 papers). Takuya Suzuki collaborates with scholars based in Japan, United States and South Korea. Takuya Suzuki's co-authors include Tatsuhiro Ishida, Hiroshi Ishihara, Kenji Hyodo, Seiichi Hayato, Hiroshi Kiwada, Toshiyuki Tamai, Takuji Okusaka, Hiromitsu Kumada, Makoto Tahara and Hiroshi Kikuchi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Takuya Suzuki

91 papers receiving 2.0k citations

Peers

Takuya Suzuki
Jianyong Yang China
Petra Rümmele Germany
Umesh C. Sharma United States
Jian Tan China
Raffaele Addeo Italy
Dapeng Li China
Kuang‐Den Chen Taiwan
Tamotsu Kuroki Japan
Masaoki Harada Japan
Hiroyuki Tanaka Japan
Jianyong Yang China
Takuya Suzuki
Citations per year, relative to Takuya Suzuki Takuya Suzuki (= 1×) peers Jianyong Yang

Countries citing papers authored by Takuya Suzuki

Since Specialization
Citations

This map shows the geographic impact of Takuya Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Suzuki more than expected).

Fields of papers citing papers by Takuya Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Suzuki. The network helps show where Takuya Suzuki may publish in the future.

Co-authorship network of co-authors of Takuya Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Suzuki. A scholar is included among the top collaborators of Takuya Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Suzuki. Takuya Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, K., Hiroki Takahashi, Takeshi Yanagita, et al.. (2024). Visualization of cecal tumor by near-infrared laparoscopy and intraoperative colonoscopy. Surgical Case Reports. 10(1).
2.
Nakata, Masanori, Takuya Suzuki, Yuko Ueda, et al.. (2024). Developmental and functional roles of androgen and interactive signals for external genitalia and erectile tissues. Reproductive Medicine and Biology. 23(1). 3 indexed citations
3.
Takahashi, Hiroki, K. Watanabe, Takeshi Yanagita, et al.. (2024). Bcl‑xL‑specific BH3 mimetic A‑1331852 suppresses proliferation of fluorouracil‑resistant colorectal cancer cells by inducing apoptosis. Oncology Reports. 53(2). 1 indexed citations
4.
Suzuki, Takuya, et al.. (2024). Anion exchange-HPLC method for evaluating the encapsulation efficiency of mRNA-loaded lipid nanoparticles using analytical quality by design. Journal of Chromatography B. 1247. 124317–124317. 4 indexed citations
5.
Ogasawara, Takayuki, Masahiko Mukaino, Takuya Suzuki, et al.. (2023). Ensemble averaging for categorical variables: Validation study of imputing lost data in 24-h recorded postures of inpatients. Frontiers in Physiology. 14. 1094946–1094946. 2 indexed citations
6.
Suzuki, Takuya, Hiroki Takahashi, Takahisa Hirokawa, et al.. (2023). AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells. Oncology Reports. 49(3). 2 indexed citations
7.
Nakai, Nozomu, Takeshi Yanagita, Takuya Suzuki, et al.. (2023). Elevated Preoperative Serum Vascular Endothelial Growth Factor Does Not Predict Poor Outcomes in Curatively Resected Non-metastatic Colorectal Cancer Treated Without Neoadjuvant Therapy. Anticancer Research. 43(5). 2333–2341. 1 indexed citations
8.
Udagawa, Hibiki, Shunji Takahashi, Motohiro Hirao, et al.. (2022). Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer. Cancer Medicine. 12(2). 1269–1278. 9 indexed citations
9.
Kiyota, Naomi, Makoto Tahara, Bruce Robinson, et al.. (2021). MO3-4 Impact of baseline tumor size on overall survival in patients with RR-DTC treated with lenvatinib (SELECT). Annals of Oncology. 32. S296–S296. 3 indexed citations
10.
Zheng, Xiangqian, Zhengang Xu, Qinghai Ji, et al.. (2021). A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer. Clinical Cancer Research. 27(20). 5502–5509. 31 indexed citations
11.
Tahara, Makoto, Naomi Kiyota, Ana O. Hoff, et al.. (2021). Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer. European Journal of Cancer. 147. 51–57. 37 indexed citations
12.
Tamura, Keita, Shunji Takahashi, Toru Mukohara, et al.. (2020). 346P Phase I study of the liposomal formulation of eribulin (E7389-LF): Results from the HER2-negative breast cancer expansion. Annals of Oncology. 31. S385–S385.
13.
14.
Mukaino, Masahiko, et al.. (2018). Estimation of exercise intensity using heart rate during sleep. Annals of Physical and Rehabilitation Medicine. 61. e447–e447. 1 indexed citations
15.
Ikeda, Masafumi, Takashi Sasaki, Chigusa Morizane, et al.. (2017). A phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: Primary analysis results. Annals of Oncology. 28. v246–v246. 11 indexed citations
16.
Ikeda, Masafumi, Takuji Okusaka, Shuichi Mitsunaga, et al.. (2015). Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research. 22(6). 1385–1394. 141 indexed citations
17.
Kikuchi, Hiroshi, Hiroshi Ishihara, & Takuya Suzuki. (2011). DDS development for drug life cycle management. Drug Delivery System. 26(2). 99–105.
18.
Igarashi, Yoshinori, et al.. (2008). THE PRESENT AND PROSPECT OF ENDOSCOPIC BILIARY STENTING. Acta gastro-enterologica belgica. 50(6). 1427–1435. 2 indexed citations
19.
Sayama, Takahiro, et al.. (2008). Evaluating the Impact of Climate Change on Flood Disasters and Dam Reservoir Operation in the Yodo River Basin. JOURNAL OF JAPAN SOCIETY OF HYDROLOGY AND WATER RESOURCES. 21(4). 296–313. 8 indexed citations
20.
Igarashi, Yoshinori, Ken Ito, Takuya Suzuki, et al.. (2004). ENDOSCOPIC PANCREATIC DRAINAGE. Acta gastro-enterologica belgica. 46(12). 2582–2588. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianyong Yang Breakdown of academic impact, for papers by Petra Rümmele Breakdown of academic impact, for papers by Umesh C. Sharma Breakdown of academic impact, for papers by Jian Tan Breakdown of academic impact, for papers by Raffaele Addeo Breakdown of academic impact, for papers by Dapeng Li Breakdown of academic impact, for papers by Kuang‐Den Chen Breakdown of academic impact, for papers by Tamotsu Kuroki Breakdown of academic impact, for papers by Masaoki Harada Breakdown of academic impact, for papers by Hiroyuki Tanaka
Rankless by CCL
2026